Regulatory Risk Mismanagement and the Abortion Pill

    Research output: Other contribution

    Abstract

    The approval of Mifegymiso has exposed the legal and practical limitations of Health Canada’s adoption of Risk Management Plans for drugs.

    Original languageCanadian English
    Publication statusPublished - Apr. 25 2017

    Publication series

    NamePolicy Options

    Keywords

    • abortion pill
    • Mifegymiso
    • risk management
    • Health Canada

    Disciplines

    • Administrative Law
    • Animal Law
    • Business Organizations Law
    • Civil Procedure
    • Commercial Law
    • Common Law
    • Comparative and Foreign Law
    • Constitutional Law
    • Contracts
    • Courts
    • Criminal Law
    • Criminal Procedure
    • Dispute Resolution and Arbitration
    • Environmental Law
    • Evidence
    • Family Law
    • Food and Drug Law
    • Health Law and Policy
    • Human Rights Law
    • Indigenous, Indian, and Aboriginal Law
    • Intellectual Property Law
    • International Humanitarian Law
    • International Law
    • Judges
    • Jurisprudence
    • Law
    • Law and Gender
    • Law and Politics
    • Law and Race
    • Law and Society
    • Law of the Sea
    • Legal Ethics and Professional Responsibility
    • Other Law
    • Privacy Law
    • Property Law and Real Estate
    • Public Law and Legal Theory
    • Securities Law
    • Tax Law
    • Torts

    Fingerprint

    Dive into the research topics of 'Regulatory Risk Mismanagement and the Abortion Pill'. Together they form a unique fingerprint.

    Cite this